WHITE PAPERS

China’s policy overhauls: What does this mean for pharmaceutical approvals?
June 2020
3.0MB

Archive

Market access challenges of advanced therapy medicinal products
January 2018
2.0MB
Impact of 2017 policy changes on China’s pharmaceutical market
January 2018
5.0MB